Professional Documents
Culture Documents
All rights reserved. The information contained herein is subject to change without notice. ©2010, Cognizant Technology Solutions
Overview
Subsidies:
Individuals and families who make between 100 percent - 400 percent of the Federal
Poverty Level (FPL) and want to purchase their own health insurance on an exchange are
eligible for subsidies.
They cannot be eligible for Medicare, Medicaid and cannot be covered by an employer.
Eligible buyers receive premium credits and there is a cap for how much they have to
contribute to their premiums on a sliding scale.
Medicare:
Closes the Medicare prescription drug "donut hole" by 2020. Seniors who hit the
donut hole by 2010 will receive a $250 rebate.
Beginning in 2011, seniors in the gap will receive a 50 percent discount on brand
name drugs. The bill also includes $500 billion in Medicare cuts over the next
decade.
The industry will have to provide 50 percent discounts beginning next year to
Medicare beneficiaries in the "doughnut hole" gap in pharmaceutical coverage,
but those price cuts plus gradually rising federal subsidies will mean more
elderly people will purchase more drugs
Medicaid:
Expands Medicaid to include 133 percent of federal poverty level which is
$29,327 for a family of four.
Requires states to expand Medicaid to include childless adults starting in 2014.
Federal Government pays 100 percent of costs for covering newly eligible
individuals through 2016.
Illegal immigrants are not eligible for Medicaid.
Huge New Market - $30 billion, 10-year net gain for the industry -
increase in revenue as more people will have insurance to pay for drug
coverage.
Requires drug companies to contribute more than $80 billion toward the
cost of reform in the form of industry fees and a 50 percent discount to
Medicare beneficiaries for drugs purchased in what is known as the
"donut hole,"
the Act bestows upon the high-growth biotechnology sector a new 12-
year window of protection from generic competition, providing additional
incentive for continued product development and investment in the
industry.
All rights reserved. The information contained herein is subject to change without notice. ©2010, Cognizant Technology Solutions